358
Views
8
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for EGFR-mutated non-small cell lung cancer

, , &
Pages 5-16 | Received 13 Sep 2018, Accepted 07 Dec 2018, Published online: 20 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Wentao Tian, Chenghui Cao, Long Shu & Fang Wu. (2020) Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer. OncoTargets and Therapy 13, pages 12113-12129.
Read now
Hongyu Xu, Lin Zhou, You Lu, Xiaomei Su, Peng Cheng, Dong Li, Hui Gao, Hua Li, Weiwei Yuan, Ling Zhang & Tao Zhang. (2020) Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases. OncoTargets and Therapy 13, pages 647-656.
Read now

Articles from other publishers (6)

Liting Wang, Hao Fu, Liwei Song, Zhihua Wu, Jian Yu, Qianqian Guo, Chuanrong Chen, Xupeng Yang, Jiali Zhang, Quan Wang, Yourong Duan & Yunhai Yang. (2022) Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP‐DRI‐12. Small 19:4, pages 2204133.
Crossref
Hayato Tada, Nobuko Kojima, Kan Yamagami, Akihiro Nomura, Atsushi Nohara, Soichiro Usui, Kenji Sakata, Noboru Fujino, Masayuki Takamura & Masa-Aki Kawashiri. (2022) Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia. Frontiers in Genetics 13.
Crossref
Shuai Hao, Qi Yang, Fannian Li, Qiancheng Li, Yuanpu Liu, Shuang Li, Lei Zhao & Chengtao Wang. (2021) Dysregulated expression of miR-642a-5p and its target receptor-interacting serine/threonine-protein kinase 1 contribute to the phycocyanin-mediated inhibitory function on non-small cell lung cancer. Journal of Functional Foods 85, pages 104654.
Crossref
Marialucia Iacovino, Vincenza Ciaramella, Fernando Paragliola, Gabriella Suarato, Gesualdina Busiello & Francesca Sparano. (2020) Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC. Exploration of Targeted Anti-tumor Therapy 1:6, pages 391-400.
Crossref
Shubham Atal, Pravin Asokan & Ratinder Jhaj. (2020) Recent advances in targeted small‐molecule inhibitor therapy for non–small‐cell lung cancer—An update. Journal of Clinical Pharmacy and Therapeutics 45:3, pages 580-584.
Crossref
Veronica Aran & Jasminka Omerovic. (2019) Current Approaches in NSCLC Targeting K-RAS and EGFR. International Journal of Molecular Sciences 20:22, pages 5701.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.